🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Bionime Corporation (TPE:4737)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
58.00
-1.10 (-1.86%)
Nov 20, 2026, 1:30 PM CST

Bionime Statistics

Total Valuation

Bionime has a market cap or net worth of TWD 4.49 billion. The enterprise value is 6.93 billion.

Market Cap4.49B
Enterprise Value 6.93B

Important Dates

The next estimated earnings date is Friday, March 12, 2027.

Earnings Date Mar 12, 2027
Ex-Dividend Date n/a

Share Statistics

Bionime has 77.33 million shares outstanding. The number of shares has increased by 10.08% in one year.

Current Share Class 77.33M
Shares Outstanding 77.33M
Shares Change (YoY) +10.08%
Shares Change (QoQ) -0.12%
Owned by Insiders (%) 11.18%
Owned by Institutions (%) 0.66%
Float 45.93M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 2.59
PB Ratio 2.25
P/TBV Ratio 4.20
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 4.00
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 0.69, with a Debt / Equity ratio of 1.38.

Current Ratio 0.69
Quick Ratio 0.42
Debt / Equity 1.38
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -5.34

Financial Efficiency

Return on equity (ROE) is -15.43% and return on invested capital (ROIC) is -7.47%.

Return on Equity (ROE) -15.43%
Return on Assets (ROA) -3.70%
Return on Invested Capital (ROIC) -7.47%
Return on Capital Employed (ROCE) -9.91%
Weighted Average Cost of Capital (WACC) 2.54%
Revenue Per Employee 3.47M
Profits Per Employee -602,936
Employee Count 500
Asset Turnover 0.31
Inventory Turnover 2.47

Taxes

Income Tax -80.04M
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -4.92% in the last 52 weeks. The beta is -0.22, so Bionime's price volatility has been lower than the market average.

Beta (5Y) -0.22
52-Week Price Change -4.92%
50-Day Moving Average 57.50
200-Day Moving Average 58.20
Relative Strength Index (RSI) 51.29
Average Volume (20 Days) 115,925

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, Bionime had revenue of TWD 1.73 billion and -301.47 million in losses. Loss per share was -4.08.

Revenue1.73B
Gross Profit 598.95M
Operating Income -329.78M
Pretax Income -378.26M
Net Income -301.47M
EBITDA -179.41M
EBIT -329.78M
Loss Per Share -4.08
Full Income Statement

Balance Sheet

The company has 334.03 million in cash and 2.77 billion in debt, with a net cash position of -2.44 billion or -31.49 per share.

Cash & Cash Equivalents 334.03M
Total Debt 2.77B
Net Cash -2.44B
Net Cash Per Share -31.49
Equity (Book Value) 2.01B
Book Value Per Share 25.87
Working Capital -696.86M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -64.16 million and capital expenditures -79.08 million, giving a free cash flow of -143.24 million.

Operating Cash Flow -64.16M
Capital Expenditures -79.08M
Depreciation & Amortization 150.37M
Net Borrowing -320.64M
Free Cash Flow -143.24M
FCF Per Share -1.85
Full Cash Flow Statement

Margins

Gross margin is 34.53%, with operating and profit margins of -19.01% and -17.38%.

Gross Margin 34.53%
Operating Margin -19.01%
Pretax Margin -21.81%
Profit Margin -17.38%
EBITDA Margin -10.34%
EBIT Margin -19.01%
FCF Margin n/a

Dividends & Yields

Bionime does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
FCF Payout Ratio n/a
Buyback Yield -10.08%
Shareholder Yield -10.08%
Earnings Yield -7.03%
FCF Yield -3.19%
Dividend Details

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a
Graham Formula Value n/a
Graham Formula Upside n/a

Stock Splits

The last stock split was on September 8, 2025. It was a forward split with a ratio of 1.0998680158.

Last Split Date Sep 8, 2025
Split Type Forward
Split Ratio 1.0998680158

Scores

Bionime has an Altman Z-Score of 0.62 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score 0.62
Piotroski F-Score 3